B. Daan Westenbrink

5.4k total citations · 2 hit papers
101 papers, 3.8k citations indexed

About

B. Daan Westenbrink is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, B. Daan Westenbrink has authored 101 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cardiology and Cardiovascular Medicine, 27 papers in Molecular Biology and 21 papers in Physiology. Recurrent topics in B. Daan Westenbrink's work include Cardiovascular Function and Risk Factors (29 papers), Erythropoietin and Anemia Treatment (17 papers) and Heart Failure Treatment and Management (17 papers). B. Daan Westenbrink is often cited by papers focused on Cardiovascular Function and Risk Factors (29 papers), Erythropoietin and Anemia Treatment (17 papers) and Heart Failure Treatment and Management (17 papers). B. Daan Westenbrink collaborates with scholars based in Netherlands, United States and Sweden. B. Daan Westenbrink's co-authors include Dirk J. van Veldhuisen, Rudolf A. de Boer, Wiek H. van Gilst, Adriaan A. Voors, Salva R. Yurista, Herman H.W. Silljé, Peter van der Meer, Pim van der Harst, Erik Lipšic and Regien G. Schoemaker and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

B. Daan Westenbrink

97 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin Improves Cardiac Function in Non-Diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction

2019 248 citations Salva R. Yurista, Herman H.W. Silljé et al. European Journal of Heart Failure profile →
Heart Failure Stimulates Tumor Growth by Circulating Factors

2018 241 citations Stephan J. L. Bakker, Dirk J. van Veldhuisen et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Daan Westenbrink Netherlands	31	2.0k	899	653	653	637	101	3.8k
Hirofumi Soejima Japan	35	2.0k 1.0×	652 0.7×	435 0.7×	631 1.0×	359 0.6×	126	3.9k
Nerea Varo Spain	37	1.9k 0.9×	896 1.0×	250 0.4×	501 0.8×	372 0.6×	85	4.3k
Ratnadeep Basu Canada	35	2.2k 1.1×	1.2k 1.3×	196 0.3×	697 1.1×	366 0.6×	52	4.1k
Shusuke Yagi Japan	32	1.3k 0.7×	1.0k 1.1×	162 0.2×	668 1.0×	402 0.6×	175	3.6k
Joëlle Bénessiano France	32	1.5k 0.7×	999 1.1×	398 0.6×	325 0.5×	687 1.1×	70	3.8k
Takeshi Soeki Japan	36	2.1k 1.0×	885 1.0×	174 0.3×	602 0.9×	520 0.8×	178	4.1k
Agneta Siegbahn Sweden	39	3.9k 1.9×	851 0.9×	552 0.8×	311 0.5×	428 0.7×	131	6.0k
Erik Lipšic Netherlands	24	1.1k 0.5×	589 0.7×	1.1k 1.7×	195 0.3×	234 0.4×	103	2.9k
Anne Grete Semb Norway	37	1.4k 0.7×	715 0.8×	510 0.8×	148 0.2×	220 0.3×	146	4.7k
Ferdinand H. Bahlmann Germany	30	960 0.5×	2.4k 2.7×	613 0.9×	472 0.7×	604 0.9×	59	5.1k

Countries citing papers authored by B. Daan Westenbrink

Since Specialization

Citations

This map shows the geographic impact of B. Daan Westenbrink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Daan Westenbrink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Daan Westenbrink more than expected).

Fields of papers citing papers by B. Daan Westenbrink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Daan Westenbrink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Daan Westenbrink. The network helps show where B. Daan Westenbrink may publish in the future.

Co-authorship network of co-authors of B. Daan Westenbrink

This figure shows the co-authorship network connecting the top 25 collaborators of B. Daan Westenbrink. A scholar is included among the top collaborators of B. Daan Westenbrink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Daan Westenbrink. B. Daan Westenbrink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cox, Moniek G.P.J., Tom E. Verstraelen, Remco de Brouwer, et al.. (2025). The role of comorbidities and lifestyle factors in disease progression of phospholamban cardiomyopathy. European Journal of Preventive Cardiology. 33(2). 297–300. 1 indexed citations

Dalen, Bas M. van, et al.. (2025). Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity. Cardiovascular Diabetology. 24(1). 71–71. 5 indexed citations

Pandey, Ambarish, Kershaw V. Patel, Matthew W. Segar, et al.. (2024). Association of High-Density Lipoprotein Parameters and Risk of Heart Failure. JACC Heart Failure. 12(7). 1242–1253. 5 indexed citations

Shalaurova, Irina, et al.. (2024). Fasting Plasma Ketone Bodies Are Associated with NT-proBNP: A Potential Mechanism to Provide Fuel for the Failing Heart. Journal of Clinical Medicine. 13(6). 1541–1541. 3 indexed citations

Gorter, Thomas M., et al.. (2024). Increased epicardial adipose tissue is associated with left atrial mechanical dysfunction in patients with heart failure with mildly reduced and preserved ejection fraction. Clinical Research in Cardiology. 114(5). 601–608. 3 indexed citations

Gorter, Thomas M., Vanessa van Empel, Olivier C. Manintveld, et al.. (2023). Obesity, epicardial adipose tissue and left atrial cardiomyopathy in patients with heart failure with preserved ejection fraction: a cardiac MRI based study. EP Europace. 25(Supplement_1). 1 indexed citations

Sánchez-Aguilera, Pablo, Camila López‐Crisosto, Ignacio Norambuena‐Soto, et al.. (2023). IGF-1 boosts mitochondrial function by a Ca2+ uptake-dependent mechanism in cultured human and rat cardiomyocytes. Frontiers in Physiology. 14. 1106662–1106662. 8 indexed citations

Yurista, Salva R., et al.. (2022). SGLT2 Inhibitors and Ketone Metabolism in Heart Failure. Journal of Lipid and Atherosclerosis. 11(1). 1–1. 55 indexed citations

Pundziūtė, Gabija, Carlijn M. van der Aalst, Jan W. Gratama, et al.. (2022). Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial. American Heart Journal. 246. 166–177. 4 indexed citations

10.

Wang, Shujin, Dietbert Neumann, B. Daan Westenbrink, et al.. (2022). Ketone Body Exposure of Cardiomyocytes Impairs Insulin Sensitivity and Contractile Function through Vacuolar-Type H+-ATPase Disassembly—Rescue by Specific Amino Acid Supplementation. International Journal of Molecular Sciences. 23(21). 12909–12909. 4 indexed citations

11.

Vermeer, M., Maria C. Bolling, Jacqueline M. Bliley, et al.. (2021). Gain-of-function mutation in ubiquitin ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues. Journal of Clinical Investigation. 131(17). 21 indexed citations

12.

Yurista, Salva R., Christopher Nguyen, Anthony Rosenzweig, Rudolf A. de Boer, & B. Daan Westenbrink. (2021). Ketone bodies for the failing heart: fuels that can fix the engine?. Trends in Endocrinology and Metabolism. 32(10). 814–826. 40 indexed citations

13.

Pávez, Mario, Pablo Sánchez-Aguilera, Nils Bömer, et al.. (2021). ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ. International Journal of Molecular Sciences. 22(9). 4427–4427. 10 indexed citations

14.

Yurista, Salva R., Timothy Matsuura, Herman H.W. Silljé, et al.. (2020). Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure. Circulation Heart Failure. 14(1). e007684–e007684. 111 indexed citations

15.

Hoes, Martijn F., Anneline S.J.M. te Riele, Monika M Gladka, et al.. (2020). Young@Heart: empowering the next generation of cardiovascular researchers. Netherlands Heart Journal. 28(S1). 25–30. 1 indexed citations

16.

Yurista, Salva R., Herman H.W. Silljé, Martin M. Dokter, et al.. (2020). Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction. Cardiovascular Drugs and Therapy. 35(5). 953–963. 5 indexed citations

17.

Tromp, Jasper, B. Daan Westenbrink, Wouter Ouwerkerk, et al.. (2018). Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. Journal of the American College of Cardiology. 72(10). 1081–1090. 208 indexed citations

18.

Westenbrink, B. Daan, Haiyun Ling, Shigeki Miyamoto, et al.. (2012). Abstract 18574: Mitochondrial Reprogramming By Camkiiδ Underlies Gq-induced Cardiomyopathy. Circulation. 126(suppl_21). 1 indexed citations

19.

Westenbrink, B. Daan, Kevin Damman, Michiel Rienstra, Alexander H. Maass, & Peter van der Meer. (2012). Heart Failure Highlights in 2011. European Journal of Heart Failure. 14(10). 1090–1096. 3 indexed citations

20.

Westenbrink, B. Daan, et al.. (2012). Abstract 18536: Camkii-{delta} Splice Variants Exert Differential Effects on Heart Failure Development and Myocardial Ischemia / Reperfusion Injury. Circulation. 126. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact